As generic versions of its blockbuster drug Ofev (nintedanib) start to hit the market, Boehringer Ingelheim GmbH looks to have swerved the patent cliff, with European and Japanese regulators both ...

Immuneering Corp. reported a median overall survival of 17.3 months in first-line metastatic pancreatic cancer patients treated with its MEK inhibitor atebimetinib (IMM-1-104) plus modified ...

Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the treatment of prion disease.

WAVES, an algorithm designed to extract menstrual-cycle metrics from physiological signals such as basal body temperature, which oscillates with sex hormones, shows how different parameters change ...

Biopharma stocks, as measured on the BioWorld Biopharmaceutical Index, underperformed both the Nasdaq Biotechnology Index and the Dow Jones Industrial Average through the first four months of 2026.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Discovery Life Sciences, Eli Lilly, Engage, Eton, Jupiter, Knight, Medtronic, Pharmala, SPR.

Cereno Scientific AB plans to initiate preclinical disease model studies evaluating CS-585 in antiphospholipid syndrome, a rare autoimmune disease associated with recurrent blood clots and serious ...

Antimicrobial-focused Tennor Therapeutics Ltd. will debut in Hong Kong May 22, having priced a HK$626.84 million (US$80 million) IPO. The Suzhou, China-based biotech is waiting on China’s National ...

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the ...

Shares of Immunovant Inc. (NASDAQ:IMVT) were up 30% in midmorning trading after the firm disclosed early but “compelling” data from a phase IIb study testing next-generation FcRn inhibitor IMVT-1402 ...

Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit activity and alleviates core behavioral ...

Clinical updates for biopharma and med tech, including data readouts and publications: Boston Scientific, Elixir, Immunitybio, Mabylon, Nexgel, Oligomerix, Relay, Sanofi, Savara, Sensome, Sustained, ...